BioSpace News Archive

Pfizer is rapidly scaling up its AI/ML efforts in a collaborative effort intended to get transformative medicines to patients faster.

Psychedelic and psychedelic-assisted therapies in the neuropsychiatric space have stalled for decades.

Sanofi and Innate Pharma expand their longtime collaboration by licensing up to three NK cells engager programs in cancer immunotherapy valued at more than $1.4 billion.

Madrigal’s NASH drug hits the mark in late-stage trial.

HUTCHMED Limited announces that it has initiated the filing of a rolling submission of a New Drug Application to the U.S. Food and Drug Administration for fruquintinib, a highly selective and potent oral inhibitor of VEGFR-1, -2 and -3, for the treatment of refractory metastatic colorectal cancer.

Formulated Solutions, a Florida-based Contract Development and Manufacturing Organization (CDMO) supporting consumer-centric innovation, expert development, and cost-effective production of consumer healthcare solutions, announced an agreement to acquire a newly updated 455,000 ft2 FDA approved pharmaceutical liquids, semi solids, aerosol, BoV, and metered dose nasal spray production facility located in Cleveland, TN.

Ascletis Pharma Inc. announces that it has received the Notice of Issuance from the United States Patent and Trademark Office for the patent application of oral viral polymerase inhibitor ASC10 and its derivatives, and their uses to treat multiple virus infections including SARS-CoV-2, monkeypox virus and respiratory syncytial virus.

RadNet, Inc. (NASDAQ: RDNT), today announced that its subsidiary DeepHealth, Inc., a leading developer of artificial intelligence (AI) for mammography interpretation, has received FDA clearance of its mammography density assessment software, Saige-Density™.

IDEAYA Biosciences, Inc. (Nasdaq:IDYA), a synthetic lethality focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced the appointment of Dr. Karlene Cimprich, Ph.D., and Dr. Kornelia Polyak, M.D., Ph.D., to its Scientific Advisory Board.

Nykode Therapeutics ASA announced that it has entered into a strategic manufacturing partnership with Richter-Helm BioLogics GmbH & Co KG to supply plasmid DNA for Nykode’s wholly owned and partnered product portfolio.